Recall Ledger

Cefazolin in Dextrose recall (Baxter Healthcare Corporation)

DrugClass IOngoing

Summary: Baxter Healthcare Corporation is recalling Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.. Reason: Presence of Particulate Matter.

What is being recalled

Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.

Why

Presence of Particulate Matter

How serious is it

Class I is the most serious level: FDA considers there is a reasonable probability that using or being exposed to this product will cause serious health problems or death.

Where it was sold

US Nationwide.

How to tell if yours is affected

Lot # LD175708, Exp Date: 14-Feb-2027.

What to do

Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.

Recall facts

Recall numberD-0787-2026
CategoryDrug
AgencyU.S. Food and Drug Administration (FDA)
SeverityClass I
StatusOngoing
Recall startedJuly 24, 2026
ReportedAugust 19, 2026
CompanyBaxter Healthcare Corporation
Company locationDeerfield, IL, United States
Initiated byVoluntary: Firm initiated
Quantity19,032 bags

More recalls from Baxter Healthcare Corporation · all drug recalls · recalls from July 2026

Official FDA record